Subscribe

Alternative Energy Partners, Inc. (AEGY)

USD0.00 +0.00 (+0.00%)
US OTC Healthcare Medical - Pharmaceuticals
Address 301 Yamato Road 33431
Boca Raton, FL, US
CEO Mario Barrera
IPO 2009-10-02
ISIN US02152E2000

Explore sections of this company profile

Description

Alternative Energy Partners, Inc. is a burgeoning company primarily dedicated to supporting medical cannabis dispensaries located in California. Its central project involves the development of PharmaJanes, a digital platform accessible via both websites and mobile applications. This innovative tool is designed to facilitate individuals' ability to order medical marijuana with ease. The firm was established in 2008 and is headquartered in Boca Raton, Florida.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.00 +0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
3M
Beta
-58.20
Float Shares
4.11B
Free Float %
100.0%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+0.00% +0.00% +9,900.00% +0.00% +0.00% +0.00% +0.00% +900.00% -66.67% +900.00% -99.99%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
0.00
Quality scores
Altman Z-Score
-59.13
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Pharmaceuticals: +7.8%
    -100.0% Q2'14: -100.0% (vs Q2'13)
  • EPS growth Medical - Pharmaceuticals: +20.2%
    -6.3% Q2'14: +350.0% (vs Q2'13)
  • FCF margin FCF growth · Medical - Pharmaceuticals: +43.3%
  • EBIT margin Medical - Pharmaceuticals: +6.8%
  • ROIC Medical - Pharmaceuticals: +6.1%
    Q2'14: -1,154.1% (vs Q2'13)
  • Share dilution Medical - Pharmaceuticals: +0.0%
    +338.9% Q2'14: +915.5% (vs Q2'13)
  • Debt / EBITDA Net debt/EBITDA · Medical - Pharmaceuticals: 0.21×
    -1,655.80× Q2'14: 0.05× (vs Q2'13)
Valuation Multiples From To
DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (-58.20) × ERP
WACC = 7% × Ke + 93% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 0.00
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Ownership data is not available for this company yet.

Executive team

Top executives
Shares Outstanding
4.11B

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Jeffrey Benz General Counsel male
Mario Barrera Chairman of the Board, Chief Executive Officer, President & Secretary male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings reports

Stock splits